RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

RSV vaccine recommended for adults 60+ with health issues, infants under 19 months, and all healthy adults 75+. Helps prevent ...

The NHS has warned of a 'serious virus' after a surge in cases of respiratory syncytial virus (RSV) in Australia. Here's ...

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

Newborn babies whose mother received the RSV vaccination during pregnancy were about 80% less likely to be admitted to ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

Pfizer (PFE 0.06%) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to fo ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

Officials estimated that 228 fewer babies younger than 3 months older were hospitalized for serious RSV infection during the ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory ...